Kalvista Pharmaceuticals, Inc. · NASDAQ:KALV
Palleiko Benjamin L sold 3,322 Kalvista Pharmaceuticals, Inc. shares (Form 4)
Traded May 11 to May 12, 2026 · Filed May 13, 2026
From May 11 to May 12, 2026, Palleiko Benjamin L (Director, CHIEF EXECUTIVE OFFICER) sold 3,322 Kalvista Pharmaceuticals, Inc. shares at US$26.71 for US$88,731, leaving 466,375 shares. Filed May 13, 2026 (Form 4).
- Sold
- 3,322 shares
- Price
- US$26.71
- Value
- US$88,731
- Holding after
- 466,375 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Option exercise | 7,120 | 469,697 | Direct | |
| May 12, 2026 | Common Stock | Sale | 3,322 | US$26.71 | 466,375 | Direct |
Source
Related
- Kalvista Pharmaceuticals, Inc.
- Palleiko Benjamin L
- Kalvista Pharmaceuticals, Inc. shareholders
- Form 4 · Palleiko Benjamin L · Jun 11, 2026
- Form 4 · Palleiko Benjamin L · May 26, 2026
- Form 4 · Palleiko Benjamin L · May 19, 2026
- Form 4 · Palleiko Benjamin L · Apr 20, 2026
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2026
- Form 4 · Audhya Paul K. · Jun 11, 2026
- Form 4 · Sweeny Nicole · Jun 11, 2026
- Form 4 · Yea Christopher · Jun 11, 2026
- Form 4 · Piekos Brian · Jun 11, 2026